Richard Champlin, MD

Richard Champlin, MD

Richard Champlin, MD 500 500 Cell Source, Inc.

Richard Champlin, MD

Principal Investigator,
Phase I II Clinical Trials
Chair, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine
MD Anderson Cancer Center
Past Chair, Center for International Blood and Marrow Transplantation Research Past President, American Society for Blood and Marrow Transplantation

Subscribe to Cell Source’s Newsletter

    INVESTOR ALERTS. PRESS RELEASES. INDUSTRY & COMPANY NEWS.

    Get the latest Cell Source news and updates, delivered right to your inbox.